HC Wainwright & Co. Reiterates Buy on I-MAB, Lowers Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Andrew Fein has reiterated a Buy rating on I-MAB (NASDAQ:IMAB) but lowered the price target from $18 to $8.
March 18, 2024 | 10:41 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
HC Wainwright & Co. reaffirmed a Buy rating on I-MAB, though the price target was reduced from $18 to $8.
The reduction in price target from $18 to $8 by a reputable analyst firm like HC Wainwright & Co. could lead to a negative short-term impact on I-MAB's stock price. This significant decrease in the price target may shake investor confidence, despite the reaffirmation of a Buy rating.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100